Altered lymphocyte distribution in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Psychiatric Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JPSYCHIRES.2006.01.010PMID 16516234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?

  2005cited by this paper
• Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines.

  2004cited by this paper
• Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia

  2004cited by this paper
• T cell response to amyloid-beta and to mitochondrial antigens in Alzheimer's disease.

  2003cited by this paper
• Immunotherapeutic Approaches to Alzheimer's Disease

  2003cited by this paper
• Telomere Dysfunction of Lymphocytes in Patients With Alzheimer Disease

  2003cited by this paper
• Autoimmunity as a special case of immunity: removing threats from within.

  2003cited by this paper
• Immunologic and inflammatory mediators and cognitive decline in Alzheimer's disease.

  2003cited by this paper
• Telomere shortening in T cells correlates with Alzheimer's disease status.

  2003cited by this paper
• T Cell Response to Amyloid-β and to Mitochondrial Antigens in Alzheimer’s Disease

  2003cited by this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid β peptide

  2002cited by this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide.

  2002cited by this paper
• Inflammation in neurodegenerative disease--a double-edged sword.

  2002cited by this paper
• Microglia as neuroprotective, immunocompetent cells of the CNS

  2002cited by this paper
• Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases.

  2002cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice.

  2001cited by this paper
• Reduced levels of amyloid β-peptide antibody in Alzheimer disease

  2001cited by this paper
• Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome.

  2000cited by this paper
• Brain‐immune connection: Immuno‐regulatory properties of CNS‐resident cells

  2000cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease.

  1998cited by this paper
• The possible role of the immune system in Alzheimer's disease.

  1998cited by this paper
• Cytokine-induced survival of activated T cells in vitro and in vivo.

  1998cited by this paper
• Neuroautoimmunity: pathogenic implications for Alzheimer's disease.

  1997cited by this paper
• APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease.

  1996cited by this paper
• T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease.

  1995cited by this paper
• Peripheral blood lymphocyte subset distribution and function in patients with Alzheimer's disease and other dementias.

  1995cited by this paper
• Studies of neuroimmune markers in Alzheimer's disease

  1994cited by this paper
• The Immunopathology of Alzheimer's Disease and Some Related Disorders

  1993cited by this paper
• Gender differences and the interpretation of genetic instability in Alzheimer's disease.

  1992cited by this paper
• Distribution of peripheral lymphocytes in Alzheimer patients and controls.

  1992cited by this paper
• The decrease of CD8-positive lymphocytes in Alzheimer's disease.

  1992cited by this paper
• Genomic Instability and Aging

  1992cited by this paper
• Reduced natural killer cell activity in patients with dementia of the Alzheimer type

  1991cited by this paper
• Immune system‐associated antigens on the surface of peripheral blood lymphocytes in patients with Alzheimer's disease

  1991cited by this paper
• Alzheimer's disease : basic mechanisms, diagnosis and therapeutic strategies

  1991cited by this paper
• Neuroimmune axis as a basis of therapy in Alzheimer's disease.

  1990cited by this paper
• Senile dementia, alzheimer type: A distinct entity in the immunosenescence?

  1990cited by this paper
• Zinc and thymic hormone-dependent immunity in normal ageing and in patients with senile dementia of the Alzheimer type.

  1990cited by this paper
• Lymphopenia in primary degenerative dementia.

  1989cited by this paper
• Functional study of T lymphocyte responsiveness in patients with dementia of the Alzheimer type.

  1989cited by this paper
• Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease.

  1988cited by this paper
• Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue.

  1988cited by this paper
• Psychoneuroimmunology: Interactions between central nervous system and immune system

  1987cited by this paper
• Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.

  1986cited by this paper
• An Analysis of T Lymphocyte Subpopulations in Patients with Alzheimer's Disease

  1985cited by this paper
• Senile dementia of Alzheimer's type (SDAT)

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Immunological indices in presenile Alzheimer's disease.

  1980cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Bringing natural killer cells to the clinic: Opportunities beyond cancer.

  2026cites this paper
• White Blood Cells in Neurodegenerative Diseases in the Context of Neuroinflammation

  2025cites this paper
• Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

  2025cites this paper
• Adaptive immunity in the neuroinflammation of Alzheimer’s disease

  2025cites this paper
• Neuroinflammation in neurodegenerative diseases: Focusing on the mediation of T lymphocytes

  2025cites this paper
• Oxidative Stress and the Role of Immune Cells in Alzheimer's Disease: Therapeutic Implications and Future Perspectives.

  2025cites this paper
• Blood-based immunophenotyping of T cell profiles in patients with neurodegenerative disorders

  2025cites this paper
• The role of CD56bright NK cells in neurodegenerative disorders

  2024cites this paper
• Expansion of peripheral cytotoxic CD4+ T cells in Alzheimer's disease: New insights from multi-omics evidence.

  2024cites this paper
• Exploring the causal role of immune cells in vascular dementia: A bidirectional mendelian randomization study.

  2024cites this paper
• Neutrophil to lymphocyte ratio in Alzheimer’s disease: A systematic review and meta-analysis

  2024cites this paper
• Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells

  2024cites this paper
• Towards early diagnosis of Alzheimer’s disease: advances in immune-related blood biomarkers and computational approaches

  2024cites this paper
• The immunomodulatory effects of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease

  2024cites this paper
• Natural killer cells in aging and age-related diseases.

  2023influential citation
• EXAMINATION OF NEUTROPHIL/LYMPHOCYTE (NLR), MONOCYTE/LYMPHOCYTE (MLR), AND PLATELET/LYMPHOCYTE (PLR) RATIOS BETWEEN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA

  2023cites this paper
• Towards early diagnosis of Alzheimer's disease: Advances in immune-related blood biomarkers and computational modeling approaches

  2023cites this paper
• A glance through the effects of CD4+ T cells, CD8+ T cells, and cytokines on Alzheimer's disease

  2023cites this paper
• Differential roles of regulatory T cells in Alzheimer's disease.

  2023cites this paper
• Low levels of peripheral blood activated and senescent T cells characterize people with HIV-1-associated neurocognitive disorders

  2023cites this paper
• The Role of T Cells in Alzheimer's Disease Pathogenesis.

  2023cites this paper
• Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline

  2023cites this paper
• Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases

  2023cites this paper
• Association of Peripheral Lymphocyte Subsets with Cognitive Decline and Dementia: The Cardiovascular Health Study

  2022cites this paper
• Neuro faces of beneficial T cells: essential in brain, impaired in aging and neurological diseases, and activated functionally by neurotransmitters and neuropeptides

  2022cites this paper
• Immunosenescence in Neurological Diseases—Is There Enough Evidence?

  2022cites this paper
• Cholesterol dysregulation in peripheral blood mononuclear cells of Alzheimer's disease.

  2022cites this paper
• Identification of circRNA-miRNA-mRNA networks to explore the molecular mechanism and immune regulation of postoperative neurocognitive disorder

  2022cites this paper
• The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases

  2022cites this paper
• HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease

  2022cites this paper
• A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease

  2022cites this paper
• The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases

  2022cites this paper
• Early alteration of peripheral blood lymphocyte subsets as a risk factor for delirium in critically ill patients after cardiac surgery: A prospective observational study

  2022cites this paper
• Acquired immunity and Alzheimer's disease

  2022cites this paper
• The role of antiviral CD8+ T cells in cognitive impairment.

  2022cites this paper
• Neuroimmune contributions to Alzheimer’s disease: a focus on human data

  2022cites this paper
• Age-Related Adaptive Immune Changes in Parkinson’s Disease

  2022cites this paper
• Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis

  2022cites this paper
• Blood-Based miRNA Biomarkers as Correlates of Brain-Based miRNA Expression

  2022cites this paper
• Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology

  2022cites this paper
• Dimethyl Fumarate as the Peripheral Blood Inflammatory Mediators Inhibitor in Prevention of Streptozotocin-Induced Neuroinflammation in Aged Rats

  2022cites this paper
• Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer’s Disease: Are Immunotherapies Effective or Off-Target?

  2021cites this paper
• Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson's diseases.

  2021cites this paper
• Association Between the Alterations in the Blood Routine Check Parameters and Cognitive Impairment in the Shenzhen Ageing-related Disorder Cohort in China

  2021cites this paper
• Age- and sex-dependent alterations in the peripheral immune system in the 3xTg-AD mouse model of Alzheimer's disease: Increased proportion of CD3+CD4-CD8- double-negative T cells in the blood.

  2021cites this paper
• Dysregulation of Systemic Immunity in Aging and Dementia

  2021cites this paper
• Role of the immune response in the pathogenesis of Alzheimer’s disease and possibilities of anti-inflammatory therapy

  2021cites this paper
• Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease.

  2021cites this paper
• Evidence for Peripheral Immune Activation in Parkinson’s Disease

  2021cites this paper
• Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer’s disease

  2021cites this paper
• Differential blood DNA methylation across Lewy body dementias

  2021cites this paper
• Neurologic and Immunologic Complications of COVID-19: Potential Long-Term Risk Factors for Alzheimer’s Disease

  2020cites this paper
• T Cell Responses to Neural Autoantigens Are Similar in Alzheimer’s Disease Patients and Age-Matched Healthy Controls

  2020cites this paper
• Natural products-based polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders.

  2020cites this paper
• Cognitive impairment is related to a reduced count of T-lymphocytes in older patients diagnosed with non-small cell lung cancer (NSCLC)

  2020cites this paper
• Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease

  2020cites this paper
• Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases

  2020cites this paper
• Drugs Modulating CD 4 + T Cells Blood-Brain Barrier Interaction in 2 Alzheimer ' s Disease 3

  2020influential citation
• Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer’s disease: an observational clinical study

  2020cites this paper
• Drugs Modulating CD4+ T Cells Blood–Brain Barrier Interaction in Alzheimer’s Disease

  2020cites this paper
• Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses

  2020cites this paper
• The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications.

  2020cites this paper
• Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson's diseases.

  2019cites this paper
• Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease

  2019influential citation
• CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

  2019cites this paper
• KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer’s Disease: Implication for the Role of Herpesvirus Infections

  2019influential citation
• Lymphocytes, Platelets, Erythrocytes, and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis.

  2019cites this paper
• The Increase of the Pro-inflammatory Double Negative (IgD−CD27−) B Cell Subset Is Related to the Severity of Alzheimer’s Disease

  2019cites this paper
• CA-30, an oligosaccharide fraction derived from Liuwei Dihuang decoction, ameliorates cognitive deterioration via the intestinal microbiome in the senescence-accelerated mouse prone 8 strain

  2019cites this paper
• New therapeutic targeting of Alzheimer’s disease with the potential use of proline-rich polypeptide complex to modulate an innate immune response - preliminary study

  2019cites this paper
• Protective and Regenerative Roles of T Cells in Central Nervous System Disorders

  2019cites this paper
• Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments

  2019cites this paper
• Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review

  2019cites this paper
• Relationship of systemic inflammation and cellular immunity with advancement of cognitive decline in patients with Alzheimer's disease

  2018cites this paper
• Inflammation caused by peripheral immune cells across into injured mouse blood brain barrier can worsen postoperative cognitive dysfunction induced by isoflurane

  2018cites this paper
• Uncovering Biologically Coherent Peripheral Signatures of Health and Risk for Alzheimer’s Disease in the Aging Brain

  2018cites this paper
• Immunogenetic Factors of Neurodegenerative Diseases: The Role of HLA Class II

  2018cites this paper
• Immunosenescence of Natural Killer Cells, Inflammation, and Alzheimer's Disease

  2018cites this paper
• Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer’s Disease Patients. Relevant Role of Neutrophils in Oxidative Stress

  2018influential citation
• Inflammation as a Possible Link Between Dyslipidemia and Alzheimer's Disease.

  2018cites this paper
• Natural Killer Cells and Alzheimer’s Disease

  2018cites this paper
• Role of the peripheral innate immune system in the development of Alzheimer's disease

  2017cites this paper
• Defining the Immune Response and Cellular Pathologies in Multiple System Atrophy

  2017cites this paper
• Immunopathology of the Nervous System

  2017cites this paper
• Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection

  2017cites this paper
• Early diagnosis of Alzheimer's disease using infrared spectroscopy of isolated blood samples followed by multivariate analyses.

  2017cites this paper
• Targeting neuroinflammation in the treatment and prevention of Alzheimer's disease

  2017cites this paper
• The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases

  2017influential citation
• Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration

  2017cites this paper
• Perforin Promotes Amyloid Beta Internalisation in Neurons

  2017cites this paper
• Mutual effect of cerebral amyloid β and peripheral lymphocytes in cognitively normal older individuals

  2017cites this paper
• Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment

  2017cites this paper
• LW-AFC, A New Formula Derived from Liuwei Dihuang Decoction, Ameliorates Cognitive Deterioration and Modulates Neuroendocrine-Immune System in SAMP8 Mouse.

  2017cites this paper
• T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers

  2017cites this paper
• Alterations in the Peripheral Immune System in Dementia

  2017cites this paper
• Serotonin system in Alzheimer's disease : from a molecular and biomarkers perspective

  2016cites this paper
• Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model

  2016cites this paper
• Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias

  2016cites this paper
• Cytomegalovirus Infection Minimally Affects the Frequencies of B-Cell Phenotypes in Peripheral Blood of Younger and Older Adults

  2016cites this paper
• Peripheral blood gene expression analysis implicates B lymphocyte proliferation and ribosomal S26 transcripts in cognitive dysfunction in people with remitted Major Depression.

  2016cites this paper